Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease.
about
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriersMachine learning amplifies the effect of parental family history of Alzheimer's disease on list learning strategyCognitive activities and cognitive performance in middle-aged adults at risk for Alzheimer's disease.White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's diseaseEmergence of mild cognitive impairment in late middle-aged adults in the wisconsin registry for Alzheimer's preventionConfirmatory factor analysis reveals a latent cognitive structure common to bipolar disorder, schizophrenia, and normal controls.An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive functionPhysical activity attenuates age-related biomarker alterations in preclinical ADEstablishing robust cognitive dimensions for characterization and differentiation of patients with Alzheimer's disease, mild cognitive impairment, frontotemporal dementia and depression.Heritability of cognitive traits among siblings with a parental history of Alzheimer's disease.Cardiorespiratory fitness is associated with brain structure, cognition, and mood in a middle-aged cohort at risk for Alzheimer's disease.Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-aged adults at risk for AD.Does the iowa gambling task measure executive function?Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's PreventionAging, Practice Effects, and Genetic Risk in the Wisconsin Registry for Alzheimer's Prevention.Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.Verbal Fluency and Early Memory Decline: Results from the Wisconsin Registry for Alzheimer's PreventionOccupational Complexity and Cognitive Reserve in a Middle-Aged Cohort at Risk for Alzheimer's Disease.Longitudinal change in neuropsychological performance using latent growth models: a study of mild cognitive impairment.Confirmatory factor analysis of the ADNI Neuropsychological Battery.Application of Latent Variable Methods to the Study of Cognitive Decline When Tests Change over Time.Mediating effect of executive function on memory in normal aging adults.Low cerebral blood flow is associated with lower memory function in metabolic syndrome.Interaction between two cholesterol metabolism genes influences memory: findings from the Wisconsin Registry for Alzheimer's PreventionStressful events, social support, and cognitive function in middle-aged adults with a family history of Alzheimer's disease.Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's DiseaseCerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease.Investigation of triggering receptor expressed on myeloid cells 2 variant in the Wisconsin Registry for Alzheimer's Prevention.A comparison of theoretical and statistically derived indices for predicting cognitive decline.Latent structure of cognitive performance in the adult children study.Invariant two-component structure of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).Factor structure of the ARIC-NCS Neuropsychological Battery: An evaluation of invariance across vascular factors and demographic characteristics.Intraindividual Cognitive Variability in Middle Age Predicts Cognitive Impairment 8-10 Years Later: Results from the Wisconsin Registry for Alzheimer's Prevention.Social support and verbal interaction are differentially associated with cognitive function in midlife and older age.Cognitive functioning in the general population: Factor structure and association with mental disorders-The neuropsychological test battery of the mental health module of the German Health Interview and Examination Survey for Adults (DEGS1-MH).The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions.The Latent Structure and Test-Retest Stability of Connected Language Measures in the Wisconsin Registry for Alzheimer's Prevention (WRAP).Peripheral versus Central Index of Metabolic Dysfunction and Associations with Clinical and Pathological Outcomes in Alzheimer's Disease.Vascular, inflammatory, and metabolic factors associated with cognition in aging persons with chronic epilepsy.
P2860
Q26849380-3F6B03BF-A691-4DF9-9998-D099DAE5CE4FQ30455024-EFAD6AE9-E57A-4D6C-9550-D9264CFB906AQ33643289-27975CC4-7B62-4F6A-AC5B-034D41FB6D0FQ33741447-65498203-1775-4CFC-A82C-97B6D11B242CQ33922707-DFC3ED15-29D4-4874-B9D9-1ECCADFBE8AEQ34025626-0293C184-2720-4AC6-943D-B304C4EBAF69Q34364368-0887BA2D-A1B9-48C4-82A0-B29011787C40Q34383169-4B336CB0-2E97-49A8-ABAF-81BDEE6902D0Q34553827-41E931D8-F5FC-486A-8794-B74F21BDE336Q34692886-C003B89A-FB1A-49F6-A690-2A438C7C5231Q35434341-118095B8-1184-4AE1-B895-07E3DD6A69D4Q35449860-9D1F2392-BA55-4000-AC62-C44D85191764Q35545514-FCAD8B26-3CDC-4015-A06A-142B0BF902B9Q35661909-467508A1-C678-4C02-8583-EBB2D6D89153Q35820280-06E7BD75-8BB9-4E93-A6B6-E99EE28A11BAQ35850411-1A01FC8E-4195-4AE5-9405-23D87FE95F91Q36062457-D2DD2BAC-1776-48E3-8E4D-DC85BACB1E3EQ36117335-E916DF81-BB3C-47A9-870B-EB940F3BFE04Q36160858-5907181C-ED9D-4215-B594-B52B795A926DQ36494594-30D3FF41-31A7-4631-B1D1-1C40FBB8C205Q36514006-2FF5A1EB-ED99-459C-BD8E-32B98F4865FFQ36760278-CDE939BB-CD10-416F-B0B0-938AD456EA02Q36941553-63A2FC15-A9B1-4759-9E96-331D27E9A27DQ37093208-3E05E533-8FA9-46A9-A31F-6506B78B2497Q37137046-67E86FCE-10FC-4F7B-8590-393CE078D400Q37161267-A4D5BFC7-064D-4DAD-A46F-48DA04BAECC4Q37442011-0580B29C-1F5D-4147-BA38-599F87D47555Q37628346-4E9EED5E-192F-4BE7-BF94-747A35BC2D1EQ37652950-12C28B47-B05D-475E-B849-4911D276B8CDQ37670399-2DE720E2-61F1-4D6E-935C-87550B6EB0B6Q38792848-94832CEC-4639-4696-A43C-52411D71FFDBQ39917934-3AF2F557-D29C-408B-8EC6-063B7A7E6118Q39931876-1D097B96-041C-4B03-8FE9-41D8FC2051B6Q42846139-0A66C8D3-BBBE-47C6-B94B-A66C78A876ADQ47309258-CAB542E0-E565-46F3-A2E4-C88F1AB014EDQ47580273-F263ED01-939D-48E5-A932-5E11A6F855DEQ47646484-ADCC1466-D3EC-478A-8C02-C95F6B189424Q47692898-3531FD14-B27B-4AC2-8AF8-4556E75CFEF8Q47716170-CF190147-6E72-48C5-AEF8-508C70980737Q47855814-9EE5986D-A203-4BEE-882F-08C8BCB047C0
P2860
Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Latent structure and factorial ...... eclinical Alzheimer's disease.
@ast
Latent structure and factorial ...... eclinical Alzheimer's disease.
@en
type
label
Latent structure and factorial ...... eclinical Alzheimer's disease.
@ast
Latent structure and factorial ...... eclinical Alzheimer's disease.
@en
prefLabel
Latent structure and factorial ...... eclinical Alzheimer's disease.
@ast
Latent structure and factorial ...... eclinical Alzheimer's disease.
@en
P2093
P2860
P356
P1433
P1476
Latent structure and factorial ...... eclinical Alzheimer's disease.
@en
P2093
Asenath La Rue
Bruce Hermann
Mark A Sager
N Maritza Dowling
P2860
P304
P356
10.1037/A0020176
P577
2010-11-01T00:00:00Z